Locations:
Search IconSearch
July 21, 2016/Cancer/News & Insight

Cancer Moonshot Plans and Priorities Becoming Clearer

National and local summits highlight needs

bolwell_650x450

In July, the Cancer Moonshot initiative organized national and local summits to discuss cancer research, treatment and prevention needs and the efforts being planned to address them.

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

Vice President Joe Biden, who heads the White House Moonshot program to accelerate the search for cures, assured summit participants that he’s good at “removing stuff,” meaning the bureaucratic red tape that can impede progress. The vice president also announced new public- and private-sector investments, policies, collaborations and other actions intended to help meet the Moonshot’s goal to make a decade of advances in cancer prevention, diagnosis, treatment and care in five years.

The latest developments are encouraging, writes Taussig Cancer Institute Chairman Brian J. Bolwell, MD, FACP, of Cleveland Clinic Cancer Center, who met Biden for a post-summit tour of Cleveland Clinic’s Langston Hughes Community Health and Education Center, which facilitates cancer prevention and screening.

Obstacles to cancer research and clinical trials, access to basic care in underserved communities and the soaring cost of cancer treatment are among the “stuff’ that the Moonshot program will need to tackle, Dr. Bolwell notes in a commentary for Fox News.

Read his full column here.

Photo Credit: ©Russell Lee

Advertisement

Related Articles

Doctors working on MGUS screening study
March 18, 2024/Cancer/Research
Pilot Study Aims for Early Identification of Multiple Myeloma Precursor Among Black Patients

First-of-its-kind research investigates the viability of standard screening to reduce the burden of late-stage cancer diagnoses

Hematologist at Cleveland Clinic
March 14, 2024/Cancer/Blood Cancers
Advances in Mantle Cell Lymphoma Treatment (Podcast)

Global R&D efforts expanding first-line and relapse therapy options for patients

Physician with patient
March 6, 2024/Cancer/Research
Targeting Uncontrolled Erythrocytosis in Polycythemia Vera with Rusfertide

Study demonstrates ability to reduce patients’ reliance on phlebotomies to stabilize hematocrit levels

Dr. Jagadeesh at Cleveland Clinic
February 28, 2024/Cancer/Blood Cancers
Treating Patient with Systemic T-Cell Lymphoma and Graft-Versus-Host Disease

A case study on the value of access to novel therapies through clinical trials

Doctor measuring patient's waist size
February 26, 2024/Cancer/Research
Impact of Obesity on GVHD & Transplant Outcomes in Hematologic Malignancies

Findings highlight an association between obesity and an increased incidence of moderate-severe disease

Physician with patient
February 21, 2024/Cancer/Research
Strategies for Improving Clinical Trial Equity

Cleveland Clinic Cancer Institute takes multi-faceted approach to increasing clinical trial access 23456

How antibody drug conjugates work
February 13, 2024/Cancer/Research
Real-World Use of Trastuzumab Deruxtecan

Key learnings from DESTINY trials

CQD-4445459-rotz-650×450
February 7, 2024/Cancer
Advances in Bone Marrow Transplant Have Improved Outcomes in Fanconi Anemia

Overall survival in patients treated since 2008 is nearly 20% higher than in earlier patients

Ad